No results for ‘’
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK BSE: 532296
₹2233.90
(1.99%)
Mon, 03 Aug 2026, 11:00 pm
Market Cap (in Cr)63023.91
PE Ratio35.07
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KGlenmark Pharmaceuticals Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 1510591 | 2173.31 | 11 Jul 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 1510591 | 2171.67 | 11 Jul 2025 |
| UBS AG | block | Sell | 264465 | 1492.65 | 25 Mar 2025 |
| INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. | block | Buy | 264465 | 1492.65 | 25 Mar 2025 |
| UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 671394 | 1510 | 23 Jan 2025 |
| UBS AG | block | Buy | 671394 | 1510 | 23 Jan 2025 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 302621 | 397.9 | 25 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 39265 | 397.9 | 25 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 39265 | 397.9 | 25 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 302621 | 397.9 | 25 Oct 2022 |
Showing 1–10 of 90
Rows per page: